Skip to content
Search

Latest Stories

PDA queries GPhC's proposal to increase registration fees for pharmacists

The Pharmacists’ Defence Association has raised apprehensions regarding the General Pharmaceutical Council’s consultation on their proposal to raise the registration fees for pharmacists, pharmacy technicians, and pharmacy premises. The PDA criticised the GPhC's justification for the fee increase as wholly inadequate.

In May, the GPhC began a consultation concerning increases in registration and renewal fees for pharmacies, pharmacists, pharmacy technicians, and traineestrain. The GPhC linked the proposed increase mainly to the substantial surge in the current inflation rate, which is currently pegged at 10 percent annually.


According to GPhC's proposal, there would be a uniform 7.5 per cent increase in fees:

  • Pharmacist renewal fees would increase by £19 from £257 to £276
  • Pharmacy technician renewal fees would increase by £9 from £121 to £130
  • Pharmacy premises renewal fees would increase by £27 from £365 to £392

In response to the regulatory body's proposal, the union noted a significant level of concern expressed in its member survey responses, particularly regarding the GPhC premises in Canary Wharf. Furthermore, there was discussion about the overlooked potential for relocating to more cost-effective office spaces elsewhere.

The GPhC failed to mention in the consultation document its commitment to allocate approximately £9.3 million in cash for acquiring fixed assets within a 24-month timeframe, as stated in the PDA's response. This expenditure includes the procurement of fixtures and fittings for its newly acquired offices in Canary Wharf.

The union pointed out that despite the regulator's transition to a more affordable office space, the GPhC still maintains its presence in the 'central financial district' of Canary Wharf. The union further emphasized that it cannot identify any evidence indicating that the GPhC explored alternative locations.

The PDA also cited the case of the General Dental Council, which transferred numerous functions to Birmingham premises, resulting in 'net savings of approximately £50 million over 15 years,' equivalent to an average of £3.33 million annually.

The GPhC is utilising registrants' funds, and the PDA has expressed its inability to support a fee increase without comprehensive disclosure on Canary Wharf office costs and a clear rationale for selecting the location based on financial considerations. The council documents indicate that comparable savings for the accommodation amount to nearly £0.9 million annually.

The regulator’s consultation document from May indicated that it would encounter a deficit unless it raises its income, as per its budget forecasting. However, the PDA contested this statement, highlighting that the regulator's 'fixed asset valuation' of £0.8 million in 2023 is projected to rise significantly to £10.1 million by 2025.

The union noted that this 'indicates' the GPhC's involvement in a significant spending effort of £9.3 million, with suspicions that a substantial portion of this expenditure is directed towards fittings at the regulator's new headquarters.

The PDA asserted that the GPhC has "not revealed" its methodology for determining the cost of regulating each group of registrants, even though the union submitted a freedom of information request to the regulator.

According to the PDA, the GPhC had not provided evidence to support its claim that fees are determined by the cost of regulating each registrant group. The union highlighted that online pharmacies now account for 'more than 30 per cent of open fitness-to-practise cases' and argued that this 'should result' in a higher fee for premises owners.

It urged the GPhC to practice complete transparency concerning its asset acquisition, particularly the expenses associated with outfitting its elaborate new office area.

The PDA members had shown strong support for a proposal to implement a concessionary system for registration fees targeting pharmacists with lower incomes.

More than 80 per cent of participants in its survey indicated that they personally covered their registration fees, thus implying that pharmacists not engaged in full-time work would experience a direct individual impact due to a fee hike, the PDA said.

Although only 30 per cent of respondents identified as part-time workers, a substantial 84 per cent favoured reduced fees for individuals with lower incomes, the Union said, adding that implementing a 'flat low-income concession' would be a more equitable approach.

The GPhC is currently reviewing consultation feedback and plans to publish an autumn report, including the PDA's response, which will influence final decisions.

Meanwhile, the GPhC recently announced plans to select five new council members from diverse professional and personal backgrounds over the next two years, coinciding with the culmination of the current members' terms. In July, the regulator revealed plans to appoint a new Chief Pharmacy Officer, thereby strengthening the professional perspective within the senior leadership team and cultivating a culture of enterprise leadership, inclusivity, and collaboration within the organisation.

More For You

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less